Valeria Loi

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial

François Quénet, Dominique Élias, Lise Roca et al. · The Lancet Oncology · 2021 · 748 citations · Full text

Cytoreductive Surgery, Surgical Oncology, Prodige 7 +8

A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7.

François Quénet, Dominique Élias, Lise Roca et al. · Journal of Clinical Oncology · 2018 · 325 citations

Surgical Oncology, Gastrointestinal Oncology, Colorectal Surgery +14

Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP–PRODIGE 15): a randomised, phase 3 study

Diane Goèré, Olivier Gléhen, François Quénet et al. · The Lancet Oncology · 2020 · 218 citations · Full text

Surgical Oncology, Gastrointestinal Oncology, Colorectal Surgery +8

Diffuse malignant peritoneal mesothelioma: Evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database

Vahan Képénékian, D. Élias, Guillaume Passot et al. · European Journal of Cancer · 2016 · 89 citations

Systemic Chemotherapy, Comprehensive Treatment, Surgical Oncology +8

A new internet tool to report peritoneal malignancy extent. PeRitOneal MalIgnancy Stage Evaluation (PROMISE) application

Laurent Villeneuve, Arnaud Thivolet, Naoual Bakrin et al. · European Journal of Surgical Oncology · 2016 · 64 citations

Surgical Oncology, Peritoneal Malignancy Extent, Gastrointestinal Oncology +10